比较氰钴胺和弥可保降低2型糖尿病小鼠同型半胱氨酸的作用  

Comparison of reducing the homocysteine level in type 2 diabetic mice between cyanocobalamin and (methylcobalamin) treatment

作　　者：杨国庆[1] 陆菊明[1] 马芳龄[1] 潘长玉[1] 

机构地区：[1]解放军总医院内分泌科,北京100853

出　　处：《中华糖尿病杂志（1006-6187）》2005年第2期142-143,共2页

摘　　要：2型糖尿病Kkay小鼠,以蛋氨酸喂养制备高胱氨酸血症模型。弥可保治疗两周同型血半胱氨酸水平明显低于氰钴胺治疗(2.2±0.2 vs 3.2±0.6μmol/L,P<0.05)In T2DM Kkay mice with hyperhomocysteinemia (HHcy)modeled by methionine feeding, the methylcobalamin-treatment group had lower Hcy level (μmol/L,±s) at the 2-nd week than that of cyanocobalamin treatment (2.2±0.2 vs 3.2±0.6,P<0.05 respectively).

关 键 词：比较氰钴胺 弥可保 2型糖尿病 小鼠 同型半胱氨酸 脑血管疾病 

分 类 号：R587.2[医药卫生—内分泌]